Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Gregory Y.H. Lip, Robby Nieuwlaat, Ron Pisters et al. · CHEST Journal · 2009 · 6.7K citations · Full text

Medicine, Cardiology, Clinical Sciences +16

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

Sam Schulman, Clive Kearon · Journal of Thrombosis and Haemostasis · 2005 · 4.9K citations

Medicine, Hematology, Pharmacology +12

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

Ron Pisters, Deirdre A. Lane, Robby Nieuwlaat et al. · CHEST Journal · 2010 · 4.5K citations · Full text

Medicine, Cardiology, Risk Assessment +14

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Craig T. January, L. Samüel Wann, Hugh Calkins et al. · Journal of the American College of Cardiology · 2019 · 2.2K citations

Medicine, Cardiology, Internal Medicine +14

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis

Paolo Prandoni, Anthonie W.A. Lensing, Andrea Piccioli et al. · Blood · 2002 · 1.9K citations · Full text

Medicine, Hematology, Oncology +16